[HTML][HTML] Current and prospective protein biomarkers of lung cancer

TN Zamay, GS Zamay, OS Kolovskaya, RA Zukov… - Cancers, 2017 - mdpi.com
Lung cancer is a malignant lung tumor with various histological variants that arise from different
cell types, such as bronchial epithelium, bronchioles, alveoli, or bronchial mucous glands…

[HTML][HTML] DNA aptamers for the characterization of histological structure of lung adenocarcinoma

…, SS Bekuzarov, AK Kirichenko, RA Zukov… - … Therapy-Nucleic Acids, 2017 - cell.com
Nucleic acid aptamers are becoming popular as molecular probes for identification and
imaging pathology and, at the same time, as a convenient platform for targeted therapy. Recent …

[HTML][HTML] The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer

…, DV Veprintsev, AE Sokolov, RA Zukov… - … Therapy-Nucleic Acids, 2021 - cell.com
Aptamers are short, single-stranded DNA or RNA oligonucleotide molecules that function as
synthetic analogs of antibodies and bind to a target molecule with high specificity. Aptamer …

[HTML][HTML] Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples

…, AV Krat, EV Slepov, AS Bukatin, RA Zukov… - Frontiers in Molecular …, 2023 - frontiersin.org
Breast cancer (BC) diagnostics lack noninvasive methods and procedures for screening and
monitoring disease dynamics. Admitted CellSearch® is used for fluid biopsy and capture of …

Nucleic Acid Aptamers Increase the Anticancer Efficiency and Reduce the Toxicity of Cisplatin-Arabinogalactan Conjugates In Vivo

…, SS Zamay, YS Pats, RA Zukov… - nucleic acid …, 2022 - liebertpub.com
Cisplatin is an effective drug for treating various cancer types. However, it is highly toxic for
both healthy and tumor cells. Therefore, there is a need to reduce its therapeutic dose and …

Bioluminescent SNP genotyping technique: Development and application for detection of melanocortin 1 receptor gene polymorphisms

…, AA Bondar, EN Eremina, EV Slepov, RA Zukov… - Talanta, 2018 - Elsevier
SNP genotyping based on the reaction of specific primer extension with the following
bioluminescent detection of its products was shown to be potentially applicable for biomedical …

[HTML][HTML] Development of DNA aptamers for visualization of glial brain tumors and detection of circulating tumor cells

…, NG Chanchikova, AV Krat, RA Zukov… - … Therapy-Nucleic Acids, 2023 - cell.com
Here, we present DNA aptamers capable of specific binding to glial tumor cells in vitro, ex
vivo, and in vivo for visualization diagnostics of central nervous system tumors. We selected …

Perioperative durvalumab for resectable non–small-cell lung cancer

…, G Galffy, M Hochmair, T Winder, R Zukov… - … England Journal of …, 2023 - Mass Medical Soc
Background Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients
with resectable non–small-cell lung cancer (NSCLC). Perioperative regimens may combine …

[HTML][HTML] Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a …

…, S Pignata, K Numakura, BC Stopa, R Zukov… - The lancet …, 2022 - thelancet.com
Background The first interim analysis of the KEYNOTE-564 study showed improved disease-free
survival with adjuvant pembrolizumab compared with placebo after surgery in patients …

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

…, M Sekacheva, R Orlova, A Vasilyev, R Zukov… - The Lancet …, 2023 - thelancet.com
Background Systemic therapies have improved the management of hepatocellular carcinoma,
but there is still a need to further enhance overall survival in first-line advanced stages. …